United States · research
United States · researchLassen Therapeutics
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
PrivateFor profit
Against its peers
Set against 1,463 research companies in United States. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 5% of those with a founding year; website ranked #5,000,506 in the world, about 2k visits a month.
About Lassen Therapeutics
BiotechnologyHealth CareLife ScienceMedicalTherapeutics
One of 1,463 research companies in United States, and of 3,254 in the industry worldwide.
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$116M
raised in total, currency not stated across 2 rounds
Last raised Dec 2023, 2 years ago
- Rounds
- 2
- Latest round
- Series b
- Investors
- 83 leading
Key facts
Who started it and how it trades.
- Founded by
- David King, Mark Barrett
Every detail we hold
Everything the source datasets list about Lassen Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Lassen Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2018
- Founders
- David King, Mark Barrett
- Industry
- research
- Categories
- Biotechnology, Health Care, Life Science, Medical, Therapeutics
Where3 fields
- City
- San Diego
- Country
- United States
- Markets
- Greater San Diego Area, West Coast, Western US
Size and reach3 fields
- Staff band
- 1-10
- Web traffic rank
- #5,000,506
- Monthly web visits
- 1,656
Show 9 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 116,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series b
- Latest round date
- Dec 2023
- Investors
- 8
- Lead investors
- 3
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Lassen Therapeutics may be growing as it has successfully secured an $85 million Series B funding round, which is a significant financial milestone indicating investor confidence and the availability of capital for further development and expansion. Additionally, the company is mentioned in the context of the growing IL-18 field, which suggests relevance in a developing area of cell therapy enhancement. Furthermore, Lassen Therapeutics is highlighted in the Fierce Biotech Fundraising Tracker for the year, which underscores its active participation in the competitive biotech fundraising landscape.
Companies like Lassen Therapeutics
research in United States: 1,463 in the directory.
Nex EyeWorcesterfounded 3 years later
EOSIOSan Franciscofounded 1 years earlier
Xaira TherapeuticsSouth San Francisco · 51-100 peoplefounded 6 years later
Red Arrow TherapeuticsCambridge · 1-10 peoplefounded 3 years later
Element BiosciencesSan Diego · 251-500 peoplefounded 1 years earlier
RegCellEmeryville · 1-10 peoplefounded 2 years earlierBuild a lead list
1,463 research companies in United States, filtered by size, age and reach, ready to export with emails on Pro.